| 368 |
352: N/A, Neurodegeneration |
386: Neuronal network function, Decreased |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 390 |
168: Decreased, Lymphocytes |
403: Suppression, Immune system |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 389 |
168: Decreased, Lymphocytes |
323: Increased, Disease susceptibility |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 388 |
152: Suppression, Inflammatory cytokines |
168: Decreased, Lymphocytes |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 387 |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
152: Suppression, Inflammatory cytokines |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 386 |
145: Induction, IKB inhibitory protein |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 385 |
122: Increase, GR activation |
145: Induction, IKB inhibitory protein |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 384 |
192: Altered, Neurophysiology |
402: Cognitive function, decreased |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 383 |
279: Thyroperoxidase, Inhibition |
402: Cognitive function, decreased |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 380 |
397: Response, Keratinocytes |
272: Activation/Proliferation, T-cells |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 379 |
398: Activation, Dendritic Cells |
272: Activation/Proliferation, T-cells |
Nov 29, 2016 |
Aug 22, 2022 |
2 AOPs
|
| 378 |
397: Response, Keratinocytes |
398: Activation, Dendritic Cells |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 377 |
396: Covalent Binding, Protein |
398: Activation, Dendritic Cells |
Nov 29, 2016 |
Nov 5, 2020 |
2 AOPs
|
| 376 |
396: Covalent Binding, Protein |
397: Response, Keratinocytes |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 370 |
227: Activation, PPARα |
289: Decrease, Translocator protein (TSPO) |
Nov 29, 2016 |
Dec 2, 2016 |
1 AOP
|
| 369 |
227: Activation, PPARα |
266: Decrease, Steroidogenic acute regulatory protein (STAR) |
Nov 29, 2016 |
Dec 2, 2016 |
1 AOP
|
| 366 |
279: Thyroperoxidase, Inhibition |
281: T4 in serum, Decreased |
Nov 29, 2016 |
Nov 18, 2025 |
4 AOPs
|
| 348 |
381: BDNF, Reduced |
382: Aberrant, Dendritic morphology |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 358 |
385: Synaptogenesis, Decreased |
386: Neuronal network function, Decreased |
Nov 29, 2016 |
May 25, 2018 |
2 AOPs
|
| 357 |
383: Reduced, Presynaptic release of glutamate |
385: Synaptogenesis, Decreased |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 356 |
382: Aberrant, Dendritic morphology |
385: Synaptogenesis, Decreased |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 355 |
55: Cell injury/death |
385: Synaptogenesis, Decreased |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 354 |
381: BDNF, Reduced |
383: Reduced, Presynaptic release of glutamate |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 353 |
381: BDNF, Reduced |
55: Cell injury/death |
Nov 29, 2016 |
Nov 29, 2016 |
2 AOPs
|
| 352 |
373: Formation, Pro-mutagenic DNA Adducts |
384: Increased, Clonal Expansion / Cell Proliferatin to form Pre-Neoplastic Altered Hepatic Foci |
Nov 29, 2016 |
Nov 29, 2016 |
None
|